清肺排毒汤及其主要药物治疗COVID-19的潜在靶点综述
本文综述了清肺排毒汤(QFPDT)及其组成药物(麻黄、柴胡、藿香、肉桂、黄芩)治疗COVID-19的潜在靶点。网络药理学研究提示其通过抗氧化、免疫调节和抗病毒等多途径发挥作用,主要涉及细胞因子风暴预防和ACE2受体结合调节两个作用集群。该方已被纳入中国COVID-19临床实践指南第6版和第7版。
要点
- 清肺排毒汤由5首经典方剂的21味中药组成,在中国10个省份报告对COVID-19有效。
- 其作用机制涉及抗氧化、免疫调节和抗病毒,关键为预防细胞因子风暴和调节ACE2受体结合。
- 临床应关注清肺排毒汤与西药的药代动力学、药效学及草药-药物相互作用。
核心结论
- 清肺排毒汤及其主要药物通过多靶点机制治疗COVID-19,包括抗氧化、免疫调节和抗病毒作用。
- 两个主要作用集群为预防细胞因子风暴和调节ACE2受体结合。
研究设计与样本
- 综述类文章,基于网络药理学支持的基础科学研究,汇总清肺排毒汤及其组成药物(麻黄、柴胡、藿香、肉桂、黄芩)的潜在治疗靶点。
主要发现
- 清肺排毒汤可防止轻症进展,并缩短症状平均持续时间和住院时间。
- 清肺排毒汤已被推荐纳入中国COVID-19临床实践指南第6版和第7版。
- 清肺排毒汤由5首经典方剂的21味中药组成,在中国10个省份报告对COVID-19有效。
临床怎么用
- 临床可考虑将清肺排毒汤用于COVID-19轻症以防止进展,并缩短症状持续时间和住院时间。
- 在整合治疗探索中,应使用真实世界数据,并纳入药代动力学、药效学和草药-药物相互作用研究。
局限性
- 大规模临床研究正在中国进行中,目前证据主要来自基础科学研究和网络药理学分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
COVID-19 has been declared a pandemic by WHO on March 11, 2020. No specific treatment and vaccine with documented safety and efficacy for the disease have been established. Hence it is of utmost importance to identify more therapeutics such as Chinese medicine formulae to meet the urgent need. Qing Fei Pai Du Tang (QFPDT), a Chinese medicine formula consisting of 21 herbs from five classical formulae has been reported to be efficacious on COVID-19 in 10 provinces in mainland China. QFPDT could prevent the progression from mild cases and shorten the average duration of symptoms and hospital stay. It has been recommended in the 6th and 7th versions of Clinical Practice Guideline on COVID-19 in China. The basic scientific studies, supported by network pharmacology, on the possible therapeutic targets of QFPDT and its constituent herbs including Ephedra sinica, Bupleurum chinense, Pogostemon cablin, Cinnamomum cassia, Scutellaria baicalensis were reviewed. The anti-oxidation, immuno-modulation and antiviral mechanisms through different pathways were collated. Two clusters of actions identified were cytokine storm prevention and angiotensin converting enzyme 2 (ACE2) receptor binding regulation. The multi-target mechanisms of QFPDT for treating viral infection in general and COVID-19 in particular were validated. While large scale clinical studies on QFPDT are being conducted in China, one should use real world data for exploration of integrative treatment with inclusion of pharmacokinetic, pharmacodynamic and herb-drug interaction studies.
引用
- Zhong LLD, Lam WC, Yang W, et al. Potential Targets for Treatment of Coronavirus Disease 2019 (COVID-19): A Review of Qing-Fei-Pai-Du-Tang and Its Major Herbs. Am J Chin Med. 2020. PMID: 32668969. doi:10.1142/S0192415X20500512
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。